Medtronic plc on Monday announced that it has inked a deal to acquire Boston-based cardiac technology firm Affera Inc. Affera develops technology aimed at treating irregular heartbeats. Specifically, ...

Medtronic is acquiring Affera Inc., a medical technology company focused on treating cardiac arrhythmias, for $925 million. While Medtronic declined Monday to share the sale price, analysts at Piper ...

First-of-its-kind, rotation-free single-shot PFA catheter supported by strong safety and efficacy data adds to the groundbreaking Affera family of technologies in Europe Successful completion of first ...

Acquisition adds mapping and navigation platform to company's cardiac ablation portfolio and brings an integrated system of diagnostic and therapeutic tools to address a broad spectrum of arrhythmias ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic w on Food and Drug Administration approval for ...

NEWTON, Mass., Dec. 20, 2021 /PRNewswire/ -- Affera Inc., a private medical device company focused on innovative cardiac arrhythmia treatment solutions, announced today that the first patient was ...

Medtronic recently announced that its acquisition of Affera, Inc. has been completed. The acquisition was previously announced to be for $925 million with a $250 million contingency, as reported by ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system combines ...

One-year clinical trial data for the next-generation, investigational, Sphere-360™ single-shot PFA catheter show impressive safety, performance, and efficiency results for paroxysmal Afib Dual-energy ...

Medtronic plc MDT recently made a major investment to advance in the prospering field of electrophysiology (EP). The company entered into a definitive agreement to acquire Boston-based, privately held ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Medtronic is starting off 2022 with a nearly $1 billion ...

GALWAY, Ireland, Jan. 23, 2026 /PRNewswire/ -- Medtronic plc (MDT), a global leader in healthcare technology, today announced two major milestones for the Affera™ Sphere-360™ catheter, a ...